HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Molina Selected Research

Moli1901

6/2005Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation.
2/2003Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Molina Research Topics

Disease

2Neoplasms (Cancer)
01/2020 - 02/2000
2Pneumonia (Pneumonitis)
03/2014 - 02/2004
2Coronary Disease (Coronary Heart Disease)
04/2003 - 08/2001
1Breast Neoplasms (Breast Cancer)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Chronic Renal Insufficiency
03/2018
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2015
1Spider Bites (Spider Bite)
04/2014
1Erysipelas
05/2012
1Cystic Fibrosis (Mucoviscidosis)
06/2005
1Shock
02/2004
1Respiratory Tract Diseases (Respiratory Tract Disease)
02/2003
1Hypertriglyceridemia
08/2001
1Essential Hypertension
08/2001
1Cardiovascular Diseases (Cardiovascular Disease)
08/2001
1Hypertension (High Blood Pressure)
08/2001
1Febrile Neutropenia
07/2001
1Fever (Fevers)
07/2001
1Neutropenia
07/2001
1Superinfection
07/2001
1Cysts
06/2001
1Infections
12/2000
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2000
1Pathologic Complete Response
03/2000
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2000
1Leukemia
03/2000
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2000

Drug/Important Bio-Agent (IBA)

2Moli1901IBA
06/2005 - 02/2003
1Lapatinib (GW572016)FDA Link
01/2020
1Kallikreins (Kallikrein)IBA
01/2020
1Conditioned Culture MediaIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1CIGB-300IBA
05/2015
1Monoclonal AntibodiesIBA
04/2014
1AntibodiesIBA
04/2014
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
03/2014
1Sodium Glutamate (Accent)IBA
03/2014
1ParaffinIBA
05/2012
1AntioxidantsIBA
04/2003
1Apolipoproteins B (ApoB)IBA
08/2001
1Glucose (Dextrose)FDA LinkGeneric
08/2001
1LipidsIBA
08/2001
1Lipoproteins (Lipoprotein)IBA
08/2001
1HDL CholesterolIBA
08/2001
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2001
1LDL CholesterolIBA
08/2001
1Triglycerides (Triacylglycerol)IBA
08/2001
1oxidized low density lipoproteinIBA
08/2001
1Anti-Bacterial Agents (Antibiotics)IBA
07/2001
1Cefpirome (HR 810)IBA
07/2001
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
07/2001
1Hypertonic Glucose SolutionIBA
06/2001

Therapy/Procedure

3Transplantation
03/2018 - 03/2000
1Critical Care (Surgical Intensive Care)
02/2004
1Duration of Therapy
07/2001
1Renal Dialysis (Hemodialysis)
12/2000
1Heart Transplantation (Grafting, Heart)
08/2000
1Therapeutics
03/2000
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2000
1Stem Cell Transplantation
02/2000